BMPR2 and pulmonary arterial hypertension: Genetic factors have been shown to contribute to up to 42% of pediatric-onset PAH, with inherited mutations in known PAH risk genes like BMPR2, TBX4, NOTCH1, and SOX 17 but also about 15% of de novo variants in novel genes with functions in vasculogenesis and remodeling [23, 24].